p16INK4A expression in cervical premalignant and malignant lesions

Experimental and Molecular Pathology

Volumn 80, Issue 2, 2006, Pages 192-196

  Lambert, Ana Paula Franco ^a   Anschau, Fernando ^a   Schmitt, Virgínia Minghelli ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Cervical cancer; HPV; HSIL; Immunohistochemistry; LSIL; p16INK4a

Indexed keywords

PROTEIN P16INK4A;

ADOLESCENT; ADULT; ARTICLE; CELL DAMAGE; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NEOPLASM; NONHUMAN; PROTEIN EXPRESSION; SAMPLE; SQUAMOUS EPITHELIUM; STATISTICAL SIGNIFICANCE; TISSUE INJURY; UTERINE CERVIX CANCER; UTERINE CERVIX DISEASE; UTERINE CERVIX DYSPLASIA; WART VIRUS; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; PAPILLOMA VIRUS; PATHOLOGY; PHYSIOLOGY; PRECANCER; UTERINE CERVIX; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES;

ADOLESCENT; ADULT; CERVIX UTERI; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; UTERINE CERVICAL NEOPLASMS;

EID: 33644554478     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexmp.2005.08.005     Document Type: Article

References (27)

1. B. Alberts, D. Bray, A. Johnson, J. Lewis, M. Raff, K. Roberts, and P. Walter Fundamentos de Biologia Celular. Uma Introdução a Biologia Molecular da Célula. Editora Artes Médicas. Porto Alegre 1999
2. H.M. Bauer, and M.M. Manos PCR detection of genital human Papillomavirus D. Persing Diagnostic Molecular Microbiology 1993 American Society for Microbiology 407 413
3. J.S. Berek Tratado de Ginecologia. 12a edição.: Guanabara Koogam, Rio de Janeiro 1998
4. F. Bringold, and M. Serrano Tumor suppressors and oncogenes in cellular senescence Exp. Gerontol. 35 2000 317 329
5. N.H. Cho, Y.T. Kim, and J.W. Kim Alteration of cell cycle in cervical tumor associated with human Papillomavirus-cyclin-dependent kinase inhibitors Yonsei Med. J. 43 6 2002 722 728
6. V.T. DeVita, S. Hellman, and S.A. Rosenberg Cancer: Principles and Practice of Oncology 2001 Lippincott Williams and Wilkins Philadelphia
7. P.J. DiSaia, and W.T. Creasman Clinical Ginecologic Oncology 5th ed. 1997 Library of Congress
8. M.V.K. Doeberitz Searching for new biomarkers for cervical cancer: molecular accidents and the interplay of Papillomavirus oncogenes and epithelial differentiation: Part I and II Papillomavirus Rep. 13 2 2002 35 74
9. INCA (Instituto Nacional do Câncer)-Ministério da Saúde (captured in 2005). Available at: http://www.inca.gov/. accessed January 21, 2005.
10. N. Jay, and A.B. Moscicki Human Papillomavirus infections in women with HIV disease: prevalence, risk, and management AIDS Read. 10 11 2000 659 668
11. INK4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri Int. J. Cancer 92 2001 276 284
12. K.M. Langosch, S. Riethdorf, A.K. Pöppighaus, L. Riethdorf, and T. Löning Expression of cyclin-dependent kinase inhibitors p16MTS1, p21WAF1 and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas Virchows Arch. 439 2001 55 61
13. INK4a overexpression and human Papillomavirus infection in small cell carcinoma of the uterine cervix Hum. Pathol. 34 8 2003 778 783
14. M. Murakami, K.J. Gurski, and M.A. Steller Human Papillomavirus vaccines for cervical cancer J. Immunother. 22 3 1999 212 218
15. INK4a as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrepTM smear J. Clin. Pathol. 56 2003 56 63
16. S. Piccinin, C. Doglioni, R. Maestro, T. Vukosavljevic, D. Gasparotto, C. D'Orazi, and M. Boiocchi p16/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progression Int. J. Cancer 74 1997 26 30
17. J. Sambrook, E.F. Fritsch, and T. Maniatis Appendix E: commonly used techniques in molecular cloning. Purification of nucleic acids Molecular Cloning: A Laboratory Manual 3rd ed. 1999 Cold Spring Harbor New York E.3 E.4 (3v)
18. T. Sano, T. Oyama, K. Kashiwabara, T. Fukuda, and T. Nakajima Expression status of p16 protein is associated with human Papillomavirus oncogenic potential in cervical and genital lesions Am. J. Pathol. 153 6 1998 1741 1748
19. T. Sano, N. Masuda, T. Oyama, and T. Nakajima Overexpression of p16 and p14ARF is associated with human Papillomavirus infection in cervical squamous cell carcinoma and dysplasia Pathol. Int. 52 2002 375 383
20. A.C. Schellekens, A. Dijkman, M.F. Aziz, B. Siregar, S. Cornain, and G.J. Fleuren Prevalence of single and multiple HPV types in cervical carcinomas in Jakarta, Indonesia Gynecol. Oncol. 93 2004 49 53
21. INK4a Exp. Cell Res. 237 1997 7 13
22. H. Skomedal, G.B. Kristensen, A.K. Lie, and R. Holm Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas Gynecol. Oncol. 73 2 1999 223 228
23. H. Tsuda, Y. Hashiguchi, S. Nishimura, N. Kawamura, T. Inoue, and K. Yamamoto Relationship between HPV typing and abnormality of G1 cell cycle regulators in cervical neoplasm Gynecol. Oncol. 91 2003 476 485
24. S.E. Waggoner Cervical Cancer The Lancet 361 2003 2217 2225
25. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, and K.V. Sh Human Papillomavirus is a necessary cause of invasive cervical cancer worldwide J. Pathol. 189 1 1999 12 19
26. P. Zhao, Y.C. Hu, and I. Talbot Expressing patterns of p16 and CDK4 correlated to prognosis in colorectal carcinoma World J. Gastroenterol. 9 10 2003 2202 2206
27. Y. Zhou, S.S. Gao, Y.X. Li, Z.M. Fan, and X. Zhao Tumor suppressor gene p16 and Rb expression in gastric cardia precancerous lesions from subjects at a high incidence area in northern China World J. Gastroenterol. 8 3 2002 423 425